Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | -1.64%2.23B | ---- | ---- | ---- | 14.46%2.26B | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | -4.56%-114.15M | ---- | ---- | ---- | -35.92%-109.17M | ---- | ---- |
| Interest expense - adjustment | ---- | ---- | ---- | -18.32%174.49M | ---- | ---- | ---- | -6.85%213.63M | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | -17.36%-58.48M | ---- | ---- | ---- | -75.70%-49.83M | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | -23.71%-10.63M | ---- | ---- | ---- | 11.68%-8.6M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -144.78%-176K | ---- | ---- | ---- | 211.90%393K | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | -144.78%-176K | ---- | ---- | ---- | -62.71%393K | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -70.72%31.85M | ---- | ---- | ---- | 17,812.54%108.76M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -70.72%31.85M | ---- | ---- | ---- | 17,812.54%108.76M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -210.12%-7.35M | ---- | ---- | ---- | 179.10%6.67M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -125.83%-1.66M | ---- | ---- | ---- | 4,445.27%6.43M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | -2,468.75%-5.69M | ---- | ---- | ---- | 102.90%240K | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | -4.17%886M | ---- | ---- | ---- | -2.21%924.5M | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | 0.83%150.72M | ---- | ---- | ---- | -9.70%149.48M | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | -6.29%709.19M | ---- | ---- | ---- | -0.57%756.75M | ---- | ---- |
| Special items | ---- | ---- | ---- | -51.77%1.68M | ---- | ---- | ---- | --3.48M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | -6.67%3.13B | ---- | ---- | ---- | 10.86%3.35B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -91.53%21K | ---- | ---- | ---- | -64.01%248K | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | 54.56%-22.48M | ---- | ---- | ---- | 83.96%-49.47M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 107.06%5.45M | ---- | ---- | ---- | -17.45%-77.23M | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 53.69%-4.35M | ---- | ---- | ---- | -37.43%-9.4M | ---- | ---- |
| Cash from business operations | ---- | -1.62%1.87B | ---- | -3.39%3.11B | ---- | 11.78%1.9B | ---- | 21.67%3.22B | ---- | 12.95%1.7B |
| Other taxs | ---- | -27.15%-349.46M | ---- | 14.01%-502.48M | ---- | 2.47%-274.85M | ---- | 19.36%-584.37M | ---- | 32.90%-281.81M |
| Interest paid - operating | ---- | 1.88%-112.3M | ---- | 6.15%-219.01M | ---- | -0.21%-114.46M | ---- | 3.00%-233.36M | ---- | -1.56%-114.22M |
| Adjustment items of business operations | 4.03%2.56B | ---- | 10.17%870.33M | ---- | 9.32%2.46B | ---- | -23.26%790M | ---- | 27.04%2.25B | ---- |
| Net cash from operations | 4.03%2.56B | -6.84%1.41B | 10.17%870.33M | -0.54%2.39B | 9.32%2.46B | 15.88%1.51B | -23.26%790M | 42.90%2.4B | 27.04%2.25B | 34.09%1.3B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 12.59%80.47M | ---- | 255.98%100.58M | ---- | 547.69%71.47M | ---- | -44.55%28.25M | ---- | -6.29%11.04M |
| Dividend received - investment | 123.42%60.46M | -17.87%11.98M | -3.68%7.12M | 17.36%58.48M | -36.81%27.06M | --14.59M | --7.39M | 28.63%49.83M | 35.22%42.82M | ---- |
| Restricted cash (increase) decrease | ---- | 13.17%550M | ---- | 131.22%336.17M | ---- | 161.91%486M | ---- | -28.21%-1.08B | ---- | -57.00%-785M |
| Sale of fixed assets | 221.60%3.12M | 263.00%2.93M | -56.39%31.4K | 98.92%7.52M | -68.51%970.89K | 3.86%808K | 96.30%72K | -71.88%3.78M | 143.64%3.08M | -1.52%778K |
| Purchase of fixed assets | -180.82%-1.86B | -12,267.81%-985.47M | -112.58%-667.45M | -72.72%-200.92M | -16.01%-663.36M | -276.74%-7.97M | -220.34%-313.98M | 33.73%-116.33M | 53.39%-571.82M | 91.16%-2.12M |
| Selling intangible assets | ---- | ---- | ---- | --6.73M | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---- | -27.17%-403.77M | ---- | -7.36%-2.15B | ---- | 32.37%-317.49M | ---- | -75.39%-2B | ---- | 55.07%-469.48M |
| Recovery of cash from investments | 25.00%3.32M | 24.99%3.32M | ---- | -93.57%14.61M | -20.00%2.66M | -97.45%2.66M | --2.66M | -75.65%227.18M | -95.65%3.32M | 36.31%104.11M |
| Cash on investment | -3,271.68%-561.1M | -3,271.61%-561.1M | -3,099.82%-526.1M | 46.85%-113.28M | 68.68%-16.64M | 89.13%-16.64M | 50.49%-16.44M | 84.09%-213.13M | 0.00%-53.13M | -361.13%-153.13M |
| Other items in the investment business | 56.80%533.03M | ---- | 205.60%553.25M | ---- | 136.71%339.93M | ---- | 121.68%181.04M | ---- | 39.90%-925.88M | ---- |
| Net cash from investment operations | -489.57%-1.82B | -657.62%-1.3B | -354.63%-633.15M | 37.45%-1.94B | 79.40%-309.38M | 118.04%233.42M | 85.59%-139.27M | -25.93%-3.1B | 44.62%-1.5B | 13.13%-1.29B |
| Net cash before financing | -65.90%732.55M | -93.98%104.89M | -63.55%237.18M | 164.47%449.65M | 187.82%2.15B | 19,156.97%1.74B | 928.46%650.73M | 10.59%-697.44M | 179.24%746.33M | 101.75%9.05M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 535.92%6.15B | 490.43%5.71B | 1,169.79%5.08B | 764.17%4.15B | 1,109.05%967.24M | 1,109.05%967.24M | 400.00%400M | -75.92%480M | -95.99%80M | -95.53%80M |
| Refund | -18.34%-1.14B | 76.02%-138.95M | -146.24%-18M | -282.31%-2.49B | -287.25%-967.51M | -158.67%-579.51M | 71.68%-7.31M | -56.82%-652.07M | 11.55%-249.84M | 8.95%-224.03M |
| Dividends paid - financing | -11.08%-1.31B | -293.23%-106.61M | 70.73%-51.16M | 3.63%-1.02B | 3.97%-1.18B | 81.95%-27.11M | -190.42%-174.8M | 4.58%-1.06B | 4.17%-1.23B | 25.36%-150.22M |
| Absorb investment income | 561.58%478.28M | 1,279.48%478.28M | ---- | 622.93%72.29M | --72.29M | --34.67M | --7.56M | -99.05%10M | --0 | ---- |
| Other items of the financing business | -1,210.46%-4.56B | -1,958.62%-4.63B | ---4.56B | ---- | ---347.74M | -1,054.52%-225.13M | ---- | 98.36%-19.5M | ---- | 98.27%-19.5M |
| Net cash from financing operations | 73.75%-381.63M | 669.29%1.31B | 100.93%452.99M | 156.55%703.46M | -4.09%-1.45B | 154.23%170.15M | 3,856.65%225.45M | -484.13%-1.24B | -498.69%-1.4B | -147.24%-313.75M |
| Effect of rate | ---- | 137.14%13K | ---- | 116.67%1K | ---- | -488.89%-35K | ---- | -103.64%-6K | --0 | --9K |
| Net Cash | -49.45%350.92M | -26.10%1.41B | -21.23%690.17M | 159.39%1.15B | 206.73%694.15M | 727.93%1.91B | 1,429.87%876.18M | -325.54%-1.94B | -9.94%-650.38M | -308.13%-304.7M |
| Begining period cash | 124.27%2.16B | 124.27%2.16B | 124.27%2.16B | -66.86%962.38M | -66.86%962.38M | -66.86%962.38M | -66.86%962.38M | -13.57%2.9B | -13.57%2.9B | -13.57%2.9B |
| Cash at the end | 51.48%2.51B | 24.22%3.57B | 54.93%2.85B | 119.82%2.12B | -26.49%1.66B | 10.64%2.88B | -37.91%1.84B | -66.86%962.38M | -18.60%2.25B | -25.87%2.6B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Hua Ming Certified Public Accountants (Special General Partnership), Ernst & Young Accounting Firm | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.